회사 소개
- 법인명: Nanjing Hanxin Pharmaceutical Technology Co.,Ltd
- 등록 국가: China
- 주소: Building C5, No.9 Weidi Road, Xianlin Street, Qixia District, Nanjing, Jiangsu, China
- 설립 연도: 2021
설명:
Nanjing Hanxin Pharmaceutical Technology Co., Ltd, established in 2017, manufactures active pharmaceutical ingredients, digestive-system drugs, and peptides. The company was recognized as a Jiangsu Provincial Technology-Advanced Service Enterprise in 2019, obtained national-level intellectual property management system certification in 2020, acquired Nanjing Cuccess Pharmaceutical Co., Ltd. and earned National High-tech Enterprise status in 2021, and was designated a Jiangsu Provincial Specialized, Refined, Differential, and Innovative SME in 2022. Offering CRO, CMO, and CDMO contract manufacturing with OEM, ODM, and own-brand production, the company distributes to markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
사업 활동
원료의약품(API)
원료의약품 제조업체제조업체
계약 및 아웃소싱 서비스
위탁개발생산기관 (CDMO)
판매 시장
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
주요 제품/서비스
- 원료의약품(API): Semaglutide, PDRN, Earthworm Protein, Chondroitin sulfate oligosaccharides (LetopCS) ® ）, GABA（ γ- Aminobutyric acid, Ergothione, Acetic acid ganerik (chemical synthesis), Acetylated sodium hyaluronate, Cationic sodium hyaluronate, Chloroacetyl catechol, DeGu insulin side chain, Epinephrine (chemical synthesis), Liraglutide 31 peptide main chain, Liraglutide (recombinant), NmHA ® Nano sodium hyaluronate, Norepinephrine bitartrate (chemically synthesized), Recombinant CPB, Recombinant EK, Recombinant Kex II, Recombinant type III collagen protein, Smegglutide 29 peptide main chain, Smegglutide side chain
- 천연추출물 & 생약원료: Animal extracts
- 생물유래 & 발효원료: Biological fermentation raw materials
- ATC 분류체계 (해부치료화학분류): Insulin Aspart
당사 제품 & 서비스
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
인증
FDA
GMP Formulation Facility
FDA- and GMP-compliant manufacturing site producing injectables
FDA inspections with zero Form 483 observations
FDA approval for oncology
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기